United Therapeutics UTHR Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by United Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about United Therapeutics's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is United Therapeutics's short-term investments?
- United Therapeutics (UTHR) reported short-term investments of $874M in Q1 2026.
- How has United Therapeutics's short-term investments changed year-over-year?
- United Therapeutics's short-term investments decreased by 38.5% year-over-year, from $1.42B to $874M.
- What is the long-term trend for United Therapeutics's short-term investments?
- Over 5 years (2020 to 2025), United Therapeutics's short-term investments has grown at a 4.5% compound annual growth rate (CAGR), from $1.1B to $1.36B.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.